These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study. Simpson DM, Messina J, Xie F, Hale M. Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282 [Abstract] [Full Text] [Related]
23. Intravenous flumazenil versus oxazepam tapering in the treatment of benzodiazepine withdrawal: a randomized, placebo-controlled study. Gerra G, Zaimovic A, Giusti F, Moi G, Brewer C. Addict Biol; 2002 Oct; 7(4):385-95. PubMed ID: 14578014 [Abstract] [Full Text] [Related]
33. Clinical experience with the benzodiazepine antagonist flumazenil in suspected benzodiazepine or ethanol poisoning. Martens F, Köppel C, Ibe K, Wagemann A, Tenczer J. J Toxicol Clin Toxicol; 1990 Jul; 28(3):341-56. PubMed ID: 2231833 [Abstract] [Full Text] [Related]
34. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period. Kress HG, Orońska A, Kaczmarek Z, Kaasa S, Colberg T, Nolte T. Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386 [Abstract] [Full Text] [Related]